MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |